Charles Landen headshot
CL

Charles N. Landen

Associate Professor
Unit: School of Medicine
Department: Department of Obstetrics and Gynecology
Office location and address
Gynecologic Oncology
81 Hospital Dr
Charlottesville, Virginia 22903
Education
MS, Cancer Biology, University of Texas Health Sciences Center, Houston
MD, Medicine, University of North Carolina at Chapel Hill
BS, Biology, University of North Carolina at Chapel Hill
Biography

Dr. Landen grew up in North Carolina, and trained there and in Charleston, Houston and Birmingham before coming to UVA. Outside of work he enjoys speding time with his family, hiking, camping, cycling and attending sporting events.

Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer
Source: U.S. NIH Cancer Institute
March 01, 2020 – February 28, 2025
Endocervical microRNA profiling for early detection of ovarian cance
Source: The Honorable Tina Brozman Foundation, Inc.
September 01, 2019 – December 31, 2021
MD-OBGY Pre Salpingo-oophrectomy Pilot Study of MAKO 7 Device Performance
Source: nVision Medical Corporation
December 21, 2016 – December 20, 2021
The nCYT Study: A Powered Study to Evaluate the Sensitivity and Specificity of Cytological Evaluation of Fallopian Tube Samples Collected by the MAKO 7 in Determining the Presence of Malignancy - Boston Scientific Corporation
Source: Boston Scientific Corporation
March 11, 2020 – March 05, 2021
The nCYT Study: A Powered Study to Evaluate the Sensitivity and Specificity of Cytological Evaluation of Fallopian Tube Samples Collected by the MAKO 7 in Determining the Presence of Malignancy
Source: nVision Medical Corporation
August 06, 2018 – December 31, 2020
MD-OBGY Detection of early stage ovarian cancer through vaginal sampling
Source: The Honorable Tina Brozman Foundation, Inc.
January 01, 2017 – December 31, 2020
MD-OBGY Exceptional responders Pilot Study: Molecular Profiling of Tumors from Cancer Patients who are Exceptional Responders
Source: PPD Development, Inc.
March 25, 2015 – June 22, 2018
MD-OBGY-DNA repair enzyme tyrosyl-DNA phoshodleslerase-UAB DOD
Source: University Of Alabama
October 30, 2015 – September 29, 2017
MD-OBGY-OC130322 - Developing ovarian cancer stem-like cell targeted therapy to prevent disease recurrence
Source: Board of Regents of the University of Michigan
September 22, 2014 – September 21, 2016
MD-OBGY Characterization and Targeting of the ALDH Subpopulation in Ovarian Cancer
Source: U.S. DOD - Army - Medical Research Acquisition Act
January 07, 2015 – July 06, 2016
Cancer Center Support Grant - Year 21
Source: U.S. NIH Cancer Institute
June 05, 2012 – January 31, 2016
MD-OBGY Targeting Ribosomal RNA Synthesis for Treatment of Ovarian Cancer - ABOG
Source: Washington University, The
September 01, 2014 – August 31, 2015
MD-OBGY Targeting Ribosomal RNA Synthesis for Treatment of Ovarian Cancer-ACOG
Source: Washington University, The
September 01, 2014 – August 31, 2015
MD-OBGY Targeting Ribosomal RNA Synthesis for Treatment of Ovarian Cancer
Source: Washington University, The
September 01, 2014 – August 31, 2015
MD-OBGY Targeting Ribosomal RNA Synthesis for Treatment of Ovarian Cancer
Source: The American College of Obstetricians & Gynecologi
September 01, 2014 – August 31, 2015
MD-OBGY Glycosylation-Dependent Mechanisms Regulating Ovarian Tumor Cell Survival
Source: University Of Alabama
May 15, 2014 – March 31, 2015
PATH 9995: Topical Research
Credits: 1–12
Original research on approved problems.
PATH 9999: Non-Topical Research
Credits: 1–12
Dissertation research credit for students who have completed their advancement to candidacy.
  • 2010-2018 Best Doctors in America® List 
  • 2006 Gynecologic Cancer Foundation / Carol's Cause Outstanding Paper Award
  • ACOG Donald F. Richardson Memorial Prize Paper Award
  • Del and Dennis McCarthy Award for Advances in Surgery
  • AACR Scholar-in-Training Award
  • The Diane Denson Tobola Fellowship in Ovarian Cancer Research
  • Bristol-Myers Squibb Poster Award in Clinical/Translational Research
  • Reproductive Scientist Development Program
  • John R. Durant Award for Excellence in Cancer Research
  • Department of Defense Ovarian Cancer Academy Award Scholar